Dear All

Please can I ask you to share any experience you have of the use of the Yumizen H500 in Haematology/Oncology settings? 

We have a service that is well-established at a community hospital. Since Covid this site has seen a substantial shift in patient population as it has been established as a green hospital, and services have been shifted from the main, acute site. Our Haematologists are seeing more patients, and more complex patients there, including oncology and various other conditions. They have complained about results differing from the main lab (which is at the acute hospital a few miles down the road, so they need POCT in the clinic to make timely decisions). Many of the results from the analyser are marked with *, meaning that they should not be acted upon (in these instances the samples are mixed and rerun, and if still "*" a sticker is attached to the printed reported warning clinicians not to act on asterisked results). The particular problem that they have highlighted is falsely raised platelets in ITP patients - we have discussed this with the manufacturer, and it is down to the simplified technology in these analysers compared to lab machines. 

I would be grateful to hear from any of you with machines in similar settings about how your users are getting along with them, please, and whether you have seen issues such as I have described?

Thanks in advance, 
Fiona

Clinical Scientist (Biochemist)
Point of Care Testing
Berkshire and Surrey Pathology Services

########################################################################

To unsubscribe from the ACB-POCT list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=ACB-POCT&A=1

This message was issued to members of www.jiscmail.ac.uk/ACB-POCT, a mailing list hosted by www.jiscmail.ac.uk, terms & conditions are available at https://www.jiscmail.ac.uk/policyandsecurity/